PGAP3 Gene Hyperphosphatasia with mental retardation syndrome type 4 NGS Genetic Test
Short Name: PGAP3 NGS Test
Also known as: Mabry Syndrome, Hyperphosphatasia with Mental Retardation Syndrome 4, PGAP3-Related HPMRS
PGAP3 Gene Hyperphosphatasia with mental retardation syndrome type 4 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically delivered within 3 to 4 weeks after sample receipt.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Pasupathy Arumugam
Consultant Pathologist · Reg: 21521
Last updated: September 7, 2026
Overview
The purpose of this test is to confirm a clinical diagnosis of PGAP3-HPMRS4 by identifying pathogenic variants in the PGAP3 gene. It is also used for carrier testing in at-risk family members and for prenatal diagnosis in families with a known mutation. NGS technology allows simultaneous analysis of multiple genes if needed, but this test specifically targets the PGAP3 gene. NGS genetic DNA test detecets for variant and mutation detection in PGAP3 gene for Hyperphosphatasia with mental retardation syndrome type 4
- Test Code
- 5791
- CPT Code
- 81407
- ICD Code
- Q87.8
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Reports are typically delivered within 3 to 4 weeks after sample receipt.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
PGAP3 Gene Hyperphosphatasia with Mental Retardation Syndrome Type 4 (PGAP3-HPMRS4) is a rare genetic disorder that affects the nervous system and causes intellectual disability. It is caused by mutations in the PGAP3 gene, which is responsible for producing a protein that plays a role in the formation of the cell membrane. This syndrome is also known as Mabry syndrome or hyperphosphatasia with mental retardation syndrome (HPMRS).
Symptoms of PGAP3-HPMRS4
PGAP3-HPMRS4 is characterized by intellectual disability, delayed speech and motor development, seizures, and abnormal muscle tone. Patients with this syndrome may also have distinctive facial features, such as a small head circumference, a small jaw, and a prominent forehead. In addition, they may have skeletal abnormalities, including joint stiffness, scoliosis, and abnormal bone growth. Some patients may also have liver and kidney problems.
Diagnosis of PGAP3-HPMRS4
Diagnosis of PGAP3-HPMRS4 is based on the patient's clinical features, family history, and genetic testing. A thorough physical examination, including neurological and skeletal assessments, is essential. Doctors may also perform brain imaging studies, such as an MRI or CT scan, to assess brain structure and function. Genetic testing, including Next-Generation Sequencing (NGS) DNA testing, can confirm the diagnosis by identifying mutations in the PGAP3 gene.
NGS Genetic DNA Test Cost in India
The cost of NGS genetic DNA testing in India can vary depending on the laboratory and the specific test ordered. The cost of PGAP3-HPMRS4 testing using NGS technology is approximately INR 20,000. However, this cost may vary based on the laboratory's location, quality of testing, and other factors. Patients should consult with their healthcare provider or a genetic counselor to determine the most appropriate testing options and associated costs.
Conclusion
PGAP3-HPMRS4 is a rare genetic disorder that can cause significant intellectual disability and physical impairments. Early diagnosis through a combination of clinical evaluation and genetic testing is essential for proper management and treatment. NGS genetic DNA testing is an effective tool for identifying mutations in the PGAP3 gene and confirming a diagnosis of PGAP3-HPMRS4. Patients and their families should consult with a healthcare provider or genetic counselor to discuss testing options and associated costs.
If you are looking for a reliable and accurate DNA testing laboratory in India, DNA Labs India can help. We offer a range of genetic testing services, including NGS DNA testing for PGAP3-HPMRS4. Contact us today to learn more about our services and how we can assist you.
Sample Collection
No special preparation is required. However, a genetic counseling session is recommended prior to testing to discuss the purpose, risks, and benefits. Please bring any relevant medical records or family history.
Method: Venipuncture or Fingerstick
Laboratory Analysis
Blood sample will be collected by a trained phlebotomist. For FTA card, a simple fingerstick blood spot is collected. The procedure is quick and minimally invasive.
Report Delivery
No specific aftercare is needed. You can resume normal activities immediately. The sample will be transported to the laboratory for analysis.
Timeline: Reports are typically delivered within 3 to 4 weeks after sample receipt.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to confirm a clinical diagnosis of PGAP3-HPMRS4 by identifying pathogenic variants in the PGAP3 gene. It is also used for carrier testing in at-risk family members and for prenatal diagnosis in families with a known mutation. NGS technology allows simultaneous analysis of multiple genes if needed, but this test specifically targets the PGAP3 gene.
NGS genetic DNA test detecets for variant and mutation detection in PGAP3 gene for Hyperphosphatasia with mental retardation syndrome type 4
How to Prepare
- Ensure the sample is labeled correctly with patient details.
- For blood sample, use EDTA tube and mix gently.
- For FTA card, apply blood spots and allow to air dry completely.
- Transport samples at ambient temperature to the laboratory.
Doctor's Notes
Reviewed by Dr Pasupathy Arumugam — MBBS, MD (Pathology) · Reg. No. 21521
"Early genetic confirmation of PGAP3-HPMRS4 is crucial for appropriate management and family counseling. NGS-based testing provides a comprehensive analysis of the PGAP3 gene, aiding in accurate diagnosis."
Last updated: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed or clotted blood sample
- Insufficient sample volume
- Improperly labeled sample
- Sample received after prolonged transit without proper storage
Understanding Your Results
Pathogenic variant detected
Confirms diagnosis of PGAP3-HPMRS4. Genetic counseling and family testing recommended.
Variant of uncertain significance (VUS)
Further testing or family segregation analysis may be needed to clarify significance.
No pathogenic variant detected
Does not rule out PGAP3-HPMRS4 if clinical suspicion is high; consider other genetic causes.
Consult a clinical geneticist or pediatric neurologist if your child shows developmental delay, seizures, or characteristic facial features. Genetic counseling is advised before and after testing.
Limitations
- ⚠This test detects mutations in the PGAP3 gene only; other genes causing similar phenotypes are not analyzed.
- ⚠Variant of uncertain significance (VUS) may be reported; further family studies may be needed.
- ⚠NGS may not detect large deletions/duplications or deep intronic variants; additional testing may be required if clinical suspicion is high.
- ⚠Genetic counseling is recommended to interpret results and discuss implications.
Risks & Considerations
- ●Minimal risk of bruising or infection at blood draw site
- ●Psychological impact of genetic results
- ●Potential for incidental findings (unlikely with targeted test)
Interfering Factors
- ●Inadequate sample quantity or poor DNA quality
- ●Contamination during sample collection
- ●Recent blood transfusion (may dilute DNA)
- ●Bone marrow transplantation (may affect results)
Compare With Similar Tests
| Test | PGAP3 Gene Hyperphosphatasia with mental retardation syndrome type 4 NGS Genetic Test | Whole Exome Sequencing (WES) | Targeted PGAP3 Sanger Sequencing | Chromosomal Microarray (CMA) |
|---|---|---|---|---|
| Comparison | PGAP3 Gene Hyperphosphatasia with mental retardation syndrome type 4 NGS Genetic Test | WES analyzes all coding regions of genes, while this test focuses only on PGAP3. WES is more comprehensive but costlier and may identify incidental findings. | Sanger sequencing is used for known familial mutations, but NGS is preferred for initial diagnosis as it can detect novel variants. | CMA detects copy number variations but does not detect single nucleotide variants in PGAP3. |
Frequently Asked Questions
What is PGAP3-HPMRS4?
How is this test performed?
What is the cost of the test?
How long does it take to get results?
Is fasting required?
Can this test be done on children?
What does a positive result mean?
What if the result is negative?
Is genetic counseling included?
Can I get a home sample collection?
What is the sample type?
Are there any risks?
Related Tests
Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.